Avandia: Another nail in the coffin

It’s one step closer to being pulled from the market:

Barbara Ryan, an analyst for Deutsche Bank Securities, said that the agency’s report ensures that “there are going to be a lot of lawsuits.” She noted that some firms were already advertising for clients.

Similar Posts:

• Medical ghost-writing influences doctors to prescribe more drugs
• Is the doctor or patient responsible for celebrity drug overdoses?
• How CTs and MRIs drive health care spending